Kalpit Patel
Stock Analyst at Wolfe Research
(4.55)
# 1,046
Out of 5,134 analysts
225
Total ratings
39.3%
Success rate
17.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Downgraded: Hold | n/a | $11.37 | - | 2 | Nov 12, 2026 | |
| SRRK Scholar Rock Holding | Downgraded: Hold | n/a | $43.21 | - | 1 | Nov 12, 2026 | |
| RYTM Rhythm Pharmaceuticals | Initiated Coverage: Buy | n/a | $115.02 | - | 1 | Sep 17, 2026 | |
| TSHA Taysha Gene Therapies | Initiated Coverage: Buy | n/a | $4.10 | - | 1 | Sep 17, 2026 | |
| VSTM Verastem | Initiated Coverage: Buy | n/a | $8.18 | - | 8 | Sep 17, 2026 | |
| ZYME Zymeworks | Initiated Coverage: Buy | n/a | $26.24 | - | 1 | Sep 17, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | n/a | $14.15 | - | 1 | Aug 16, 2026 | |
| KRYS Krystal Biotech | Reiterated: Hold | n/a | $305.23 | - | 2 | Aug 11, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $165 → $220 | $172.29 | +27.69% | 2 | Aug 10, 2026 | |
| ONC BeOne Medicines AG | Rated: Buy | $340 → $370 | $416.54 | -11.17% | 5 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $50 | $72.94 | -31.45% | 4 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $51.37 | -37.71% | 2 | Jun 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $35 | $25.50 | +37.25% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $74.40 | - | 2 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $2.04 | +194.12% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $145 | $93.99 | +54.27% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $20.03 | - | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $7.56 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $13.01 | n/a | 2 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.40 | n/a | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $60 | $127.57 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $30.87 | n/a | 17 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $28 | $3.39 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $3.37 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $4.33 | n/a | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $24 | $44.46 | n/a | 10 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $29 | $9.45 | n/a | 9 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $2 | $0.967 | n/a | 33 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.07 | n/a | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $15 | $3.12 | n/a | 5 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.54 | n/a | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $0.8387 | n/a | 14 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $0.8726 | n/a | 5 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $9.34 | n/a | 6 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $91.81 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.82 | n/a | 6 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.11 | n/a | 10 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $0.015 | n/a | 5 | Jun 7, 2022 |
Janux Therapeutics
Nov 12, 2026
Downgraded: Hold
Price Target: n/a
Current: $11.37
Upside: -
Scholar Rock Holding
Nov 12, 2026
Downgraded: Hold
Price Target: n/a
Current: $43.21
Upside: -
Rhythm Pharmaceuticals
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $115.02
Upside: -
Taysha Gene Therapies
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $4.10
Upside: -
Verastem
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $8.18
Upside: -
Zymeworks
Sep 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $26.24
Upside: -
Summit Therapeutics
Aug 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.15
Upside: -
Krystal Biotech
Aug 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $305.23
Upside: -
Revolution Medicines
Aug 10, 2026
Reiterated: Buy
Price Target: $165 → $220
Current: $172.29
Upside: +27.69%
BeOne Medicines AG
Aug 9, 2026
Rated: Buy
Price Target: $340 → $370
Current: $416.54
Upside: -11.17%
Jul 29, 2026
Reiterated: Sell
Price Target: $50
Current: $72.94
Upside: -31.45%
Jun 14, 2026
Reiterated: Buy
Price Target: $32
Current: $51.37
Upside: -37.71%
Jun 8, 2026
Upgraded: Buy
Price Target: $35
Current: $25.50
Upside: +37.25%
May 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $74.40
Upside: -
May 19, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.04
Upside: +194.12%
May 19, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $93.99
Upside: +54.27%
May 19, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $20.03
Upside: -
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $7.56
Upside: -
Jul 21, 2025
Reiterated: Buy
Price Target: $37
Current: $13.01
Upside: n/a
Jun 16, 2025
Reiterated: Buy
Price Target: $5
Current: $1.40
Upside: n/a
Jun 3, 2025
Upgraded: Buy
Price Target: $38 → $60
Current: $127.57
Upside: n/a
May 21, 2025
Reiterated: Hold
Price Target: $19
Current: $30.87
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $85 → $28
Current: $3.39
Upside: n/a
May 2, 2025
Reiterated: Hold
Price Target: $17 → $14
Current: $3.37
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $9
Current: $4.33
Upside: n/a
Mar 5, 2025
Reiterated: Hold
Price Target: $20 → $24
Current: $44.46
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $36 → $29
Current: $9.45
Upside: n/a
Feb 26, 2025
Downgraded: Hold
Price Target: $3.5 → $2
Current: $0.967
Upside: n/a
Jan 29, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $2.07
Upside: n/a
Nov 18, 2024
Reiterated: Hold
Price Target: $1 → $15
Current: $3.12
Upside: n/a
Sep 27, 2024
Reiterated: Buy
Price Target: $3
Current: $2.54
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $10 → $7
Current: $0.8387
Upside: n/a
Aug 14, 2023
Reiterated: Buy
Price Target: $12 → $14
Current: $0.8726
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $7
Current: $9.34
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $91.81
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.82
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $3.11
Upside: n/a
Jun 7, 2022
Reiterated: Buy
Price Target: $12 → $6
Current: $0.015
Upside: n/a